<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01595958</url>
  </required_header>
  <id_info>
    <org_study_id>2009.571</org_study_id>
    <secondary_id>2009-015725-37</secondary_id>
    <nct_id>NCT01595958</nct_id>
  </id_info>
  <brief_title>Cyclosporine A in Cardiac Arrest</brief_title>
  <acronym>CYRUS</acronym>
  <official_title>CYclosporine A in Non-shockable Out-of-hospital Cardiac Arrest ResUScitation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesised that cyclosporine A administration at the onset of
      cardiopulmonary resuscitation, by inhibiting the mitochondrial permeability transition pore,
      could prevent the post cardiac arrest syndrome and improve outcomes.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">March 2013</completion_date>
  <primary_completion_date type="Actual">March 2013</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sequential Organ Failure Assessment score (SOFA)</measure>
    <time_frame>At 24 hours after hospital admission</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hospital admission with return of spontaneous circulation</measure>
    <time_frame>At 24 hours following admission, at day 28, at hospital discharge (an average time frame of 7 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Survival</measure>
    <time_frame>At 24 hours following admission, at day 28, and at hospital discharge (an average time frame of 7 days)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Good cerebral outcome</measure>
    <time_frame>At 24 hours following admission, at day 28, and at hospital discharge (an average time frame of 7 days)</time_frame>
    <description>Glasgow Coma Scale and Cerebral Performance Categories</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All adverse events</measure>
    <time_frame>until hospital discharge (an average time frame of 7 days)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">796</enrollment>
  <condition>Non Shockable Out of Hospital Cardiac Arrest</condition>
  <arm_group>
    <arm_group_label>Cyclosporine A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single intravenous bolus of cyclosporine A (2.5 mg/kg) at the onset of resuscitation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>usual care of cardiac arrest</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cyclosporine A</intervention_name>
    <description>Single intravenous bolus of cyclosporine A (2.5 mg/kg) at the onset of resuscitation</description>
    <arm_group_label>Cyclosporine A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cardio-pulmonary resuscitation</intervention_name>
    <description>usual care of cardiac arrest</description>
    <arm_group_label>Cyclosporine A</arm_group_label>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Witnessed out-of-hospital cardiac arrest

          -  Non shockable cardiac rhythm

        Exclusion Criteria:

          -  Evidence of trauma

          -  Evidence of pregnancy

          -  Duration of no flow more than 30 minutes

          -  Rapidly fatal underlying disease

          -  Allergy to cyclosporin A
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurent ARGAUD, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Groupement Hospitalier Edouard Herriot,69437 Lyon Cedex 03</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical intensive care unit, Edouard Herriot Hospital</name>
      <address>
        <city>Lyon</city>
        <zip>69003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2012</study_first_submitted>
  <study_first_submitted_qc>May 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2012</study_first_posted>
  <last_update_submitted>April 30, 2014</last_update_submitted>
  <last_update_submitted_qc>April 30, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 1, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cardiac arrest</keyword>
  <keyword>heart arrest</keyword>
  <keyword>cyclosporine A</keyword>
  <keyword>post cardiac arrest syndrome</keyword>
  <keyword>protective agent</keyword>
  <keyword>multiple organ failure</keyword>
  <keyword>mitochondrial permeability transition pore</keyword>
  <keyword>mitochondria</keyword>
  <keyword>cardio-pulmonary resuscitation</keyword>
  <keyword>cardioprotection</keyword>
  <keyword>ischemia reperfusion</keyword>
  <keyword>postconditioning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclosporins</mesh_term>
    <mesh_term>Cyclosporine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

